Armata Pharmaceuticals, Inc. Logo

Armata Pharmaceuticals, Inc.

Develops bacteriophage therapeutics for antibiotic-resistant bacterial infections.

ARMP | US

Overview

Corporate Details

ISIN(s):
US04216R1023
LEI:
Country:
United States of America
Address:
5005 MCCONNELL AVE, 90066 LOS ANGELES

Description

Armata Pharmaceuticals, Inc. is a clinical-stage biotechnology company dedicated to developing pathogen-specific bacteriophage therapeutics to combat the global threat of antibiotic-resistant infections. The company's core focus is on creating precisely targeted, high-purity phage-based treatments for serious bacterial infections. This approach aims to provide an effective alternative to conventional antibiotics by eliminating harmful bacteria while preserving the patient's healthy microbiome. Armata's pipeline includes product candidates targeting multi-drug resistant pathogens, supported by its in-house cGMP manufacturing facility for clinical and commercial supply.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-01 18:17
FORM 8-K
English ZIP 271.6 KB
2025-12-01 18:15
424B5
English ZIP 243.9 KB
2025-11-12 17:16
10-Q
English ZIP 1.5 MB
2025-11-12 17:10
8-K
English ZIP 111.9 KB
2025-10-22 13:15
FORM 8-K
English ZIP 5.5 MB
2025-09-10 20:15
FORM 8-K
English ZIP 17.4 MB
2025-08-25 02:15 English ZIP 5.3 KB
2025-08-20 18:06 English ZIP 30.1 KB
2025-08-15 16:36 English ZIP 57.9 KB
2025-08-13 19:16
FORM S-8
English ZIP 84.7 KB
2025-08-13 19:15
FORM S-3
English ZIP 340.2 KB
2025-08-12 23:38 English ZIP 10.6 KB
2025-08-12 18:36
10-Q
English ZIP 1.5 MB
2025-08-12 18:16
8-K
English ZIP 401.2 KB
2025-07-14 18:05
OWNERSHIP DOCUMENT
English ZIP 7.1 KB

Automate Your Workflow. Get a real-time feed of all Armata Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Armata Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Armata Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

AVADEL PHARMACEUTICALS PLC Logo
Biopharmaceutical company developing therapies for sleep disorders, focusing on narcolepsy.
United States of America
AVDL
Avalon GloboCare Corp. Logo
Develops cell-based immunotherapies and provides precision diagnostics and lab services.
United States of America
ALBT
Avidity Biosciences, Inc. Logo
Develops a class of RNA therapeutics called Antibody Oligonucleotide Conjugates (AOCs).
United States of America
RNA
Axogen, Inc. Logo
Develops and commercializes surgical solutions for peripheral nerve repair.
United States of America
AXGN
Axsome Therapeutics, Inc. Logo
A biopharmaceutical company developing therapies for central nervous system disorders.
United States of America
AXSM
AYTU BIOPHARMA, INC Logo
A specialty pharma company developing novel therapeutics for complex CNS diseases.
United States of America
AYTU
Azitra, Inc. Logo
Clinical-stage biopharma company developing microbiome-based therapies for skin diseases.
United States of America
AZTR
Bachem Holding AG Logo
A CDMO developing and manufacturing peptides and oligonucleotides for pharma and biotech.
Switzerland
BANB
Barinthus Biotherapeutics plc. Logo
Clinical-stage biopharma developing immunotherapies that guide T cells to control disease.
United States of America
BRNS
Basilea Pharmaceutica AG Logo
Biopharmaceutical firm developing drugs for severe bacterial and fungal infections.
Switzerland
BSLN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.